Combination treatment with FTD/TPI and DC101 exerted an additive effect; hence, to investigate the underlying mechanism, we performed LC/MS/MS analysis to determine the FTD levels in CT26 tumor DNA on day 8 (Figure 3). Here, DDX53 is linked to neoplasm.